Aurora Cannabis (ACB) Cash from Financing Activities (2017 - 2025)
Aurora Cannabis (ACB) reported Cash from Financing Activities of $2.1 million for Q1 2025, up 158.1% year-over-year from $813846.8 in Q1 2024, and up 367.24% quarter-over-quarter from -$786000.0 in Q4 2024.
Aurora Cannabis (ACB) Cash from Financing Activities (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Cash from Financing Activities data on file, last reported at $2.1 million in Q1 2025.
- Cash from Financing Activities for Q1 2025 came in at $2.1 million, up 158.1% year-over-year; the trailing twelve-month figure through Mar 2025 was -$391708.4 (up 98.9% YoY), and the FY2025 annual result was $10453.7, up 100.03% from the prior year.
- Cash from Financing Activities climbed to $2.1 million in Q1 2025 per ACB's latest filing, from -$786000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $129.9 million in Q1 2021 and troughed at -$48.1 million in Q2 2021.
- A 5-year average of $12.0 million and a median of -$786000.0 in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2021 and 2022: Cash from Financing Activities sank 1215.42% in 2021, then jumped 201.21% in 2022.
- A 5-year view of Cash from Financing Activities shows it stood at -$7.4 million in 2021, then plunged by 519.11% to -$46.0 million in 2022, then soared by 124.23% to $11.1 million in 2023, then slumped by 107.06% to -$786000.0 in 2024, then jumped by 367.24% to $2.1 million in 2025.
- Business Quant data shows ACB's Cash from Financing Activities at $2.1 million in Q1 2025, -$786000.0 in Q4 2024, and $2.9 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | -18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | -786,000.00 |
| Dec 31, 2024 | -786,000.00 |
| Sep 30, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | -4.61 Mn |
| Jun 30, 2024 | -4.61 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Dec 31, 2023 | 11.13 Mn |
| Dec 31, 2023 | 11.13 Mn |
| Sep 30, 2023 | 2.79 Mn |
| Sep 30, 2023 | 2.79 Mn |
| Dec 31, 2022 | -45.96 Mn |
| Dec 31, 2022 | -45.96 Mn |
| Sep 30, 2022 | -7.39 Mn |
| Sep 30, 2022 | -7.39 Mn |
| Jun 30, 2022 | 48.66 Mn |
| Jun 30, 2022 | 48.66 Mn |